|Place of Origin:||CHINA|
|Model Number:||Antineoplastic Drugs API - 64|
|Minimum Order Quantity:||1KG|
|Packaging Details:||Aluminum foil bag, fiber can, kraft paper bag|
|Delivery Time:||Within 7 days|
|Supply Ability:||Can be customized according to customer requirements|
chemical raw materials,
pharmaceutical raw materials
Olaparib CAS 763113-22-0 Pharmaceutical Grade Chemicals
Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair. Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy.
Olaparib as a maintenance therapy or monotherapy for the treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. On January 12, 2018, FDA expanded the approved use of Olaparib to include chemotherapy-experienced patients with germline breast cancer susceptibility gene (BRCA) mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
We can customize according to customer's requirement.
If you have any question pls mail us or call us.